SG11202100116TA - Method of using a gip/glp1 co-agonist for diabetes - Google Patents
Method of using a gip/glp1 co-agonist for diabetesInfo
- Publication number
- SG11202100116TA SG11202100116TA SG11202100116TA SG11202100116TA SG11202100116TA SG 11202100116T A SG11202100116T A SG 11202100116TA SG 11202100116T A SG11202100116T A SG 11202100116TA SG 11202100116T A SG11202100116T A SG 11202100116TA SG 11202100116T A SG11202100116T A SG 11202100116TA
- Authority
- SG
- Singapore
- Prior art keywords
- glp1
- gip
- agonist
- diabetes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862702180P | 2018-07-23 | 2018-07-23 | |
| US201862730562P | 2018-09-13 | 2018-09-13 | |
| US201862740640P | 2018-10-03 | 2018-10-03 | |
| PCT/US2019/042824 WO2020023388A1 (en) | 2018-07-23 | 2019-07-22 | Method of using a gip/glp1 co-agonist for diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202100116TA true SG11202100116TA (en) | 2021-02-25 |
Family
ID=67544389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202100116TA SG11202100116TA (en) | 2018-07-23 | 2019-07-22 | Method of using a gip/glp1 co-agonist for diabetes |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230293638A1 (en) |
| EP (1) | EP3826662A1 (en) |
| JP (3) | JP2021530544A (en) |
| KR (1) | KR20210024081A (en) |
| CN (1) | CN112469431A (en) |
| AU (1) | AU2019309798A1 (en) |
| BR (1) | BR112020026020A2 (en) |
| CA (1) | CA3107108A1 (en) |
| IL (2) | IL308674A (en) |
| MA (1) | MA53378A (en) |
| MX (1) | MX2021000792A (en) |
| SG (1) | SG11202100116TA (en) |
| WO (1) | WO2020023388A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202216746A (en) | 2020-06-22 | 2022-05-01 | 印度商太陽製藥工業有限公司 | Long acting glp-1/gip dual agonists |
| IL299701A (en) | 2020-07-22 | 2023-03-01 | Novo Nordisk As | Co-agonists at glp-1 and gip receptors suitable for oral delivery |
| IL301109A (en) | 2020-10-17 | 2023-05-01 | Sun Pharmaceutical Ind Ltd | Glp-1/gip dual agonists |
| CA3208873A1 (en) * | 2021-02-17 | 2022-08-25 | Mathijs Christiaan Michael BUNCK | Gip/glp1 dual agonist therapeutic methods |
| TW202330584A (en) | 2022-01-20 | 2023-08-01 | 丹麥商諾佛 儂迪克股份有限公司 | Prodrugs and uses thereof |
| CN116854805B (en) * | 2023-09-05 | 2023-12-15 | 杭州湃肽生化科技有限公司 | Preparation method of telipopeptide |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013029062A2 (en) * | 2011-05-13 | 2016-11-29 | Sanofi Aventis Deutschland | lixisenatide and metformin for the treatment of type 2 diabetes |
| NZ702333A (en) | 2012-05-03 | 2017-06-30 | Zealand Pharma As | Gip-glp-1 dual agonist compounds and methods |
| EP3033355A1 (en) * | 2013-08-16 | 2016-06-22 | Medimmune Limited | Gip and glp-1 receptor dual-agonists for the treatment of diabetes |
| JOP20200119A1 (en) * | 2015-01-09 | 2017-06-16 | Lilly Co Eli | Gip and glp-1 co-agonist compounds |
| US20170112897A1 (en) * | 2015-10-23 | 2017-04-27 | Cedars-Sinai Medical Center | Methods for treating brain insulin resistance |
| TWI622596B (en) * | 2015-10-26 | 2018-05-01 | 美國禮來大藥廠 | Glucagon receptor agonists |
| MX2021000793A (en) * | 2018-07-23 | 2021-04-12 | Lilly Co Eli | Gip/glp1 co-agonist compounds. |
-
2019
- 2019-07-22 KR KR1020217002278A patent/KR20210024081A/en not_active Application Discontinuation
- 2019-07-22 EP EP19749938.7A patent/EP3826662A1/en active Pending
- 2019-07-22 JP JP2021503596A patent/JP2021530544A/en active Pending
- 2019-07-22 IL IL308674A patent/IL308674A/en unknown
- 2019-07-22 SG SG11202100116TA patent/SG11202100116TA/en unknown
- 2019-07-22 MX MX2021000792A patent/MX2021000792A/en unknown
- 2019-07-22 MA MA053378A patent/MA53378A/en unknown
- 2019-07-22 AU AU2019309798A patent/AU2019309798A1/en not_active Abandoned
- 2019-07-22 WO PCT/US2019/042824 patent/WO2020023388A1/en unknown
- 2019-07-22 IL IL280159A patent/IL280159B2/en unknown
- 2019-07-22 BR BR112020026020-7A patent/BR112020026020A2/en unknown
- 2019-07-22 US US17/260,279 patent/US20230293638A1/en active Pending
- 2019-07-22 CN CN201980048741.8A patent/CN112469431A/en active Pending
- 2019-07-22 CA CA3107108A patent/CA3107108A1/en active Pending
-
2022
- 2022-09-12 JP JP2022144239A patent/JP2022177118A/en active Pending
-
2024
- 2024-02-13 JP JP2024019543A patent/JP2024056852A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN112469431A (en) | 2021-03-09 |
| MA53378A (en) | 2021-06-02 |
| EP3826662A1 (en) | 2021-06-02 |
| JP2022177118A (en) | 2022-11-30 |
| JP2024056852A (en) | 2024-04-23 |
| IL280159B2 (en) | 2024-05-01 |
| IL308674A (en) | 2024-01-01 |
| CA3107108A1 (en) | 2020-01-30 |
| US20230293638A1 (en) | 2023-09-21 |
| WO2020023388A1 (en) | 2020-01-30 |
| IL280159B1 (en) | 2024-01-01 |
| JP2021530544A (en) | 2021-11-11 |
| IL280159A (en) | 2021-03-01 |
| BR112020026020A2 (en) | 2021-03-23 |
| MX2021000792A (en) | 2021-06-15 |
| KR20210024081A (en) | 2021-03-04 |
| AU2019309798A1 (en) | 2021-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279827A (en) | Gip/glp1 co-agonist compounds | |
| IL280159A (en) | Method of using a gip/glp1 co-agonist for diabetes | |
| IL280258A (en) | Methods of using a gip/glp1 co-agonist for therapy | |
| IL284446A (en) | Process for preparing a gip/glp1 dual agonist | |
| EP3815144C0 (en) | Manufacturing method of a display apparatus | |
| GB201915444D0 (en) | Method of using a blockchain | |
| PT3766255T (en) | Method for obtaining information about a luminaire | |
| GB201805954D0 (en) | A method | |
| GB201804627D0 (en) | A method of communicating | |
| EP3776213A4 (en) | Method of debugging a processor | |
| GB2582844B (en) | Method of assembling a structure | |
| SG11202105311VA (en) | Method of identifying a structure | |
| GB201902908D0 (en) | Method of using a blockchain | |
| PL3902898T3 (en) | A method for treating lipid materials | |
| GB2576886B (en) | A method of analysing images | |
| GB201810544D0 (en) | Method of debugging a device | |
| IL280423A (en) | A method for identifying intermediates | |
| SG11202105280QA (en) | Method of identifying a structure | |
| SG11202100009YA (en) | A method of detecting hfmd | |
| GB201817935D0 (en) | Method of replacing a module | |
| AU2024202616A1 (en) | Method Of Using A GIP/GLP1 Co-Agonist For Diabetes | |
| ZA202006375B (en) | A method of carbonizate purification | |
| HK1247889A1 (en) | Method for press-rolling a timepiece mainspring | |
| GB201813730D0 (en) | A method | |
| GB201807855D0 (en) | Method for fabricating a component of an abatement apparatus |